Combination with BT942 and PD1 antibody resulted higher increase in these immune cell population percentage in the tumor, with p-values of 0.035 for CD45+and 0.02 for CD8+ T cells when compared to vehicle (Fig. 7b,d). This evidence concerns the gene PTPRC and neoplasm.